Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New MRI scan could sharpen view of Children's brain arteries

NCT ID NCT05026060

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 38 times

Summary

This study tests a new MRI technique called eASL that may better measure blood flow in the brains of children with arterial diseases like Moyamoya or sickle cell disease. The standard MRI method often misses changes in blood flow timing. Researchers will compare the new 4-minute scan to the standard one in 50 children. If eASL works better, it could improve diagnosis and treatment planning without any extra injections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL ARTERIOPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Necker-Enfants Malades

    RECRUITING

    Paris, 75015, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

eASL MRI sequence

What this could lead to

If successful, this could lead to more accurate brain imaging for children with arterial disease, helping doctors make better treatment decisions.

What could go wrong

This is a small, early-stage study (50 children) focused on imaging accuracy, not treatment. The new method may not prove better than standard MRI.

Conditions

The condition(s) this trial relates to.

cerebral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.